http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
Jin Won Cho 한국당과학회 2017 한국당과학회 학술대회 Vol.2017 No.01
While it is the DNA sequence which holds the information deciding the amino acid sequence of the resulting proteins, in order to fully comprehend the entirety of the structures and functions of proteins in an organism, further information than just the amino acid sequence is a necessity. Of the numerous modifications that occur on proteins, glycosylation is a field in the limelight in post-genome research. In February of 2003 the Massachusetts Institute of Technology published an article on “10 Emerging Technologies that will change the world” – glycobiology was selected in the field of biotechnology, therefore its potential and merit acknowledged, and since then research in the field has been burgeoning in the USA and Japan. Before Dr. Gerald Hart of Johns Hopkins University School of Medicine had discovered the existence of nuclear and cytosolic O-GlcNAc modification in 1984, complex carbohydrates were known to exist only in the endoplasmic reticulum, the Golgi apparatus and outside the cell, thus until now researches conducted on complex carbohydrates were limited to the endomembrane system. However, when O-GlcNAc modification was revealed to be closely involved with diabetes, Alzheimer’s disease and tumorigenesis, as well as that it competes against phosphatase for the modification sites on serine and threonine residues, the biological functions of O-GlcNAc modification, more specifically its role in cell signal transduction became the focal point of researches on molecular and individual levels. 3% of all glucose that enter the cell pass through the hexosamine biosynthesis pathway and are converted into UDP-GlcNAc. Utilizing UDP-GlcNAc as its substrate, O-GlcNAc modification is a modification unlike its predecessors in that its level is dynamically regulated by O-GlcNAc trasferase (OGT) which attaches O-GlcNAc onto target proteins, and reversibly removed by O-GlcNAcase (OGA). Proteomics and glycomics research technologies have determined that over 1,800 proteins are modified by O-GlcNAc, but due to a slowed development of technological infrastructure with which to recognize and study the function of O-GlcNAc modification, locating O-GlcNAc modification sites of a protein has only recently become an active field of research. There are only around 100 proteins of which the exact modified amino acid and its resulting functions are known – a vastly small number compared to the number of proteins known to possess O-GlcNAc modification as aforementioned.
Han Byeol Kim,Sang-WonLee,ChinHeeMun,JiYoungYoon,JaeyoungPai,InjaeShin,Yong-BeomPark,Soo-KonLee,JinWonCho 한국당과학회 2016 한국당과학회 학술대회 Vol.2016 No.01
O-linked N-acetylglucosamine (O-GlcNAc) modification is unique glycosylations and it can occur exclusively in nucleus and cytoplasm. O-GlcNAc is attached onto a serine or threonine residue of a protein by O-GlcNAc transferase (OGT) and detached by O-GlcNAcase (OGA) under dynamic regulations by a variety of conditions. O-GlcNAcylation is associated with several clinical situations including cancers and inflammatory diseases. The effect of O-GlcNAcylation of subunits of nuclear factor-ĸB on its transcriptional activity has been reported to date. Interestingly, O-GlcNAc modification of NF-ĸB exhibited reciprocal results on its activity depending on different cell types: increased O-GlcNAcylation elevated the activity of NF-ĸB in pancreatic cancer cells, while aortic smooth muscle cells showed negative correlation between O-GlcNAcylation and NF-ĸB activity In Rheumatoid Arthirtis (RA), NF-ĸB is the novel regulator of pro-inflammatory cytokines mediating synovitis, long-term cartilage degradation and bone erosion. We hypothesize that the alteration in the activity of NF-ĸB resulting from its O-GlcNAcylation might affect the severity of RA. There was no report on the effect of O-GlcNAcylation of NF-ĸB on its activity in RA. We used in vitro synoviocytes and in vivo in mice with collagen induced arthritis (CIA) and investigated the inflammatory potential of O-GlcNAcylation of P65, one of subunits of NF-ĸB, in the pathogenesis of RA.